Introduction
============

Bilateral convergent strabismus with exophthalmos (BCSE) is a heritable eye defect that ccurs in many cattle breeds, e.g., Jersey, German Fleckvieh, German Holstein, and German Brown \[[@r1]-[@r4]\]. The incidence of BCSE was estimated to be 0.9% in German Brown cattle \[[@r2]\]. This eye defect is characterized by a progressive, bilateral symmetric anterior-medial rotation of the eyes that is associated with a slight to severe protrusion of the eyeballs. This defect can result in complete blindness. In the development of the bilateral convergent strabismus, a defect in the lateral rectus muscle and the retractor bulbi muscle of the eye or in their appendant nerves (*Nervus abducens* and *Nervus oculomotorius*) might be involved. Histopathological examination of the nuclei of abducens nerves showed significant differences between BCSE-affected and unaffected cows in the number of nerve cells. BCSE-affected animals had a decreased number of nerve cells in both nuclear regions (*Nuclei n. abducentis dexter* and *sinister*), and this may be related with paresis of the *M. rectus lateralis* and the lateral parts of *M. retractor bulbi*, which is also involved in lateral eye movement \[[@r5]\]. The histomorphological examination of the lateral and medial rectus muscles of BSCE-affected cows revealed "ragged red fibers," which are indicators for defects in the respiratory chain of muscles \[[@r6]\].

The defect sometimes causes changes in the behavior of the affected animals such as aggressiveness, shying, and panic in everyday situations. The first signs of BCSE can appear as early as the age of six months, but most of the affected animals are not noticed before first breeding. This eye anomaly is incurable \[[@r1]\].

In a previously performed whole genome scan using multipoint non-parametric linkage and haplotype analysis in a total of 159 German Brown cattle, we identified a genomic region harboring a locus responsible for BCSE on bovine chromosome 18 (BTA18) \[[@r7]\]. We mapped this BCSE locus to a 6.83 cM interval ([MARC-USDA](http://www.marc.usda.gov/genome/cattle/cattle.html) linkage map) on the telomeric end of BTA18 between the microsatellites, *BMS2785* (72.01 cM) and *BM6507* (78.84 cM), using linkage and haplotype analysis. The Zmean and LOD score peaked at marker *DIK5109* (77.60 cM) \[[@r5]\]. This BCSE region corresponds to a 7.77 Mb interval between 55.23 Mb (*BMS2785*) and 63.0 Mb (*BM6507*). These marker positions were determined using [BLAST](http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9913) analysis for Btau_4.0 (*Bos taurus* genome assembly 4.0).

We could identify misinnervation syndromes in humans with similarities in pathology and clinical features to BCSE in cattle. Progressive external ophthalmoplegia (PEO), Duane retraction syndrome (DRS), and congenital fibrosis of the extraocular muscles (CFEOM) belong to this group of diseases in humans. PEOs are characterized by slowly progressive bilateral immobility of the eyes accompanied by ptosis. The three candidate genes, *POLG* \[[@r8]\], *ANT1* \[[@r9]\], and *C10orf2* \[[@r10]\], for PEO were ruled out as responsible for BCSE \[[@r1],[@r11]\]. CFEOM \[[@r12]\] and DRS \[[@r13],[@r14]\] belong to a group of congenital cranial nerve dysinnervation disorders (CCDD) affecting the eye, eye lid, and/or facial movement \[[@r15]\]. The various forms of CFEOM \[[@r12]\] result from dysinnervation of the oculomotor nerve innervated ocular muscles and /or trochlear nerve innervated ocular muscles. Genes or loci causing the CFEOM phenotypes include *KIF21A* (*CFEOM1*) on centromeric HSA12q12 \[[@r16],[@r17]\], *ARIX* (*CFEOM2*) on HSA11q.13.3-q13.4 \[[@r18]\], *CFEOM3* on HSA16q24.2-q24.3 \[[@r19]\], and *CFEOM3A* on HSA12p11.2-q12 \[[@r20]\]. The bovine syntenic regions for these genes or loci are on BTA5, 9.7 Mb distally of the Quantitative Trait Locus (QTL) for BCSE (*KIF21A*), on BTA15 at 51.34 Mb (*ARIX*), and on BTA18 from 11.5 to 14.0 Mb (*CFEOM3*). The loci for DRS were mapped to HSA8q13 (*DURS1*) \[[@r21]-[@r23]\] and HSA2q31 (*DURS2*) \[[@r24],[@r25]\]. The orthologous bovine loci are on BTA14 between 30.2 and 30.7 Mb (*DURS1*) and BTA2 between 14.7 and 21.3 Mb (*DURS2*). Therefore, none of these loci or genes identified for CCDD in humans are mapping within the QTL for BCSE.

Comparison of the gene order on the telomeric end of BTA18 (Btau_4.0) with the corresponding region on HSA19 (NCBI Build 36.2) showed two blocks of synteny ([Figure 1](#f1){ref-type="fig"}). The gene order within the first block from *LOC540740* to *PRKCG* is consistent with the human gene order. The second block between *EPN1* (epsin 1) and *TFPT* (TCF3 fusion partner; Btau_4.0) is inverse compared to the gene order of the human genome assembly 36.2. In our analysis, we considered the interval from *LOC540740* (54.98 Mb) to *TFPT* (63.54 Mb), which included the linked BCSE region and its flanking regions on BTA18.

![Correspondence between the telomeric region of BTA18 and syntenic region of the human genome on HSA19. The location of the genes and candidate genes (**bold**) in which PCR products were designed are shown. Microsatellites used in the previous linkage study are printed in *italics*. The linked BCSE locus on BTA18 is marked with a red bar.](mv-v14-1737-f1){#f1}

The aim of this study was to identify single nucleotide polymorphisms (SNPs) associated with BCSE within the previously determined BCSE region and within the coding sequence of possible candidate genes contained in this region. Candidate genes were chosen due to their expression profile and their proximity to the microsatellite, *DIK5109*.

The first candidate gene, troponin T type 1 (*TNNT1*), is located about 200 kb proximal of DIK5109 at 62.50 Mb. The protein product of *TNNT1* is a component of the thin filament of the sarcomere and has the function to prevent actin-myosin interaction in resting muscle. *TNNT1* is highly expressed in skeletal muscles \[[@r26]\]. The second candidate gene, retinol dehydrogenase 13 (*RDH13*), is located in close vicinity to *TNNT1* at 62.70 Mb. *RDH13* belongs to the short-chain dehydrogenases/reductases (SDR) family and is mostly expressed in cranial nerve tissue and in the retina where it was detected in the inner segment of the photoreceptor cells \[[@r27]\]. Mutations causing strabismus have not yet been reported, but related genes such as *RDH5* and *RDH12* were shown to cause *fundus albipunctatus* and retinal dystrophy in human, which can be accompanied by strabismus \[[@r28],[@r29]\]. The third candidate gene, TCF3 fusion partner (*TFPT*), is ubiquitously expressed mainly in the brain, hematopoietic cell lines, and eye tissue.

Methods
=======

Animals, phenotypic data, and DNA/RNA extraction
------------------------------------------------

For our analyses, we collected blood samples from 96 unrelated German Brown cows. Of these animals, 48 were affected by BCSE and showed third or fourth stage BCSE where more than 50% of the eye was filled with sclera \[[@r30]\]. The other 48 German Brown cows were unaffected and more than six years old. Thus, these animals are very unlikely to develop the BCSE phenotype. Genomic DNA from EDTA blood samples was extracted using the QIAamp 96 Spin Blood Kit (Qiagen, Hilden, Germany).

For cDNA analysis, we took biopsies from the retina, *N. opticus*, and ocular muscles (*M. rectus lateralis* and *M. retractor bulbi*) of three unaffected and three severely affected cows (BCSE stage 3) \[[@r30]\]. These samples were taken 15--30 min after the cows were slaughtered.

Tissue samples were conserved using RNAlater solution (Qiagen). RNA was extracted from the ocular tissues using the Nucleospin RNA II-Kit (Macherey-Nagel, Düren, Germany) and transcribed into cDNA using SuperScript III Reverse Transcriptase (Invitrogen, Karlsruhe, Germany).

Gene structure, single nucleotide polymorphisms, polymerase chain reaction, and DNA sequencing
----------------------------------------------------------------------------------------------

### Bioinformatic cDNA analysis

For cDNA analyses of the candidate genes, we searched the cattle expressed sequence tag (EST) archive for ESTs and the bovine genome for annotated genes by cross-species [BLAST](http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9913) searches with the corresponding human reference mRNA sequences for *TNNT1* ([NM_003283](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=187173287)), *RDH13* ([NM_138412](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=34147533)) and *TFPT* ([NM_013342](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=142351171.)). [Table 1](#t1){ref-type="table"} gives an overview of the structure of these human genes and their orthologs in *Bos taurus*. In addition, we verified the sequence homology between the proteins of the three candidate genes in cattle, mouse, and human using the [ClustalW](http://www.ebi.ac.uk/Tools/clustalw/index.html) alignment program ([Figure 2](#f2){ref-type="fig"}).

###### Candidate genes.

  **Gene**   ***Homo sapiens* (36.2)**                           ***Bos taurus* (4.0)**                                                                        
  ---------- --------------------------------------------------- ------------------------ ------- ------ ---- ---- ------- ------ ---------------------------- ----
  *TNNT1*    troponin T type 1 (skeletal, slow)                  19                       16378   980    14   18   9366    887    9 - 800 (exon 1-exon 13)     13
  *RDH13*    retinol dehydroge-nase 13 (all-trans/9-cis)         19                       25191   2006   8    18   16985   3025   119 - 1126 (exon 1-exon 7)   7
  *TFPT*     TCF3 (E2A) fusion partner (in childhood leukemia)   19                       8707    1077   7    18   7644    879    62 - 817 (exon 1-exon 6)     6

An overview about the structure of the candidate genes, *TNNT1*, *RDH13*, and *TFPT* of *Homo sapiens* in comparison to *Bos taurus* is given.

![Alignment of RDH13, TNNT1 and TFPT proteins with known human and mouse orthologs. **A**: Shown are the protein sequences of RDH13 for cattle, man and mouse. **B**: Shown are the protein sequences of TNNT1 for cattle, man and mouse. **C**: Shown are the protein sequences of TFPT for cattle, man and mouse. Bovine protein sequences were derived from our analyzed coding sequences, which were similar to the published bovine protein sequences ([NP_001068813.1](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=115496474.), [NP_776899.1](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=41386697), and [NP_001068742.1](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=115497230)). The sequences were derived from [GenBank](http://www.ncbi.nlm.nih.gov/sites/entrez) entries with the accession numbers [NP_612421](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=19923931) (human RDH13), [NP_780581](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=30425078) (mouse RDH13), [NP_003274](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=187173288) (human TNNT1), [NP_035748](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=6755841) (mouse TNNT1), [NP_037474](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=7019371) (human TFPT), and [NP_076013](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=13122606) (mouse TFPT). Identical residues are indicated by asterisks beneath the alignment. The exons are labeled by different colors.](mv-v14-1737-f2){#f2}

We found a bovine EST ([EE371552](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=112231945)), isolated from muscle tissue with 89% identity to the human *TNNT1* mRNA sequence, and the bovine mRNA of *TNNT1* ([NM_174474](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=41386696)) with an identity of 90% to human *TNNT1* mRNA ([NM_003283](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=187173287)).

For *RDH13*, we found two overlapping bovine ESTs ([DV925005](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=82981334) and [DV828503](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=82688696)), which cover 77% of the human mRNA sequence with an identity of 88% and the bovine mRNA of *RDH13* ([NM_001075345](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=115496473)). The first EST ([DV925005](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=82981334)) was isolated from the skin of an embryo and the second ([DV828503](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=82688696)) from fetal pons.

We found three overlapping bovine ESTs ([DV851209](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=82757647), [CO881320](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=51811249), and [CO873631](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=51803474)) that were isolated from brain tissue covering the whole human *TFPT* mRNA sequence with an identity of 86%. Furthermore, we identified the bovine *TFPT* employing a genomic [BLAST](http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9913) analysis with the bovine mRNA sequence ([NM_001075274](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=115497229)).

We amplified the cDNA sequence corresponding to the open reading frames (ORF) of the three candidate genes. We used the ESTs and the annotated gene information for primer design with [Primer3](http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) software ([Table 2](#t2){ref-type="table"}).

###### cDNA PCR primers.

  **Gene**   **Target**   **Primer**         **Primer location**   **Primer sequence (5′-3′)**   **Annealing Temperature (°C)**   **Product Size (bp)**
  ---------- ------------ ------------------ --------------------- ----------------------------- -------------------------------- -----------------------
  *TNNT1*    cDNA         TNNT1ex1--9_F      Exon 1                GCCGAAGAGCAAGAATATGA          58 °C                            492
                          TNNT1ex1--9_R      Exon 9                GACCAGATAACCCCCAAAAT                                           
                          TNNT1ex8--13_F     Exon 8                GCTTCAGAACCGAGAAGGA           58 °C                            533
                          TNNTex8--13_R      Exon 13               CCCAGATGGACACACACC                                             
                          TNNT_ex4_F\_cDNA   Exon 1/2              AGAGGAGCAGCCCTGAAGA           60 °C                            172
                          TNNT_ex4_R\_cDNA   Exon 6                ATGTCATCGAAGTCCACACG                                           
  *RDH13*    cDNA         RDH13_cF1          Exon 1                GCGCTCTAGGTGCAGACTCCG         60 °C                            714
                          RDH13_cR1          Exon 5                CTCAGCTCCTTGGTGGAGAC                                           
                          RDH13_cF2          Exon 3                GAAGTCCATCCGAGAGTTCG          60 °C                            789
                          RDH13_cR2          Exon 7                GGCATGACAGCTAGGTTTGG                                           
  *TFPT*     cDNA         TFPT_ex1_F         Exon 1                GAGCCCGATAAACAGACTCG          60 °C                            655
                          TFPTex1--2_R       Exon 3                GCTGGAGTCTCCGAGTTATTC                                          
                          TFPTex1--2_F       Exon 2                GTGGGCTTCGAGGAGTTC            60 °C                            689
                          TFPT_ex6_R         Exon 6                TAGGGCAGCAGTTTGTCTGG                                           

The PCR primers for the amplification of the cDNA of bovine *TNNT1*, *RDH13*, and *TFPT* are shown.

### Genomic DNA sequence analysis for single nucleotide polymorphism detection

For these analyses we employed four BCSE-affected German Brown cows and four controls of the same breed. First, we designed exon flanking intronic primer pairs for the genomic amplification of all exons of *RDH13* and the exons of *TNNT1* and *TFPT*, which harbored SNPs detected by cDNA analyses ([Table 3](#t3){ref-type="table"}). Furthermore, we designed primer pairs for four polymerase chain reaction (PCR) products of these candidate genes for SNP detection within intronic regions ([Table 4](#t4){ref-type="table"}). To cover the whole region of 8.56 Mb extending between LOC540740 and *TFPT*, we screened 17 more genes for DNA polymorphisms. A total of 21 amplicons was sequenced ([Table 4](#t4){ref-type="table"}). We used the DNA of eight German Brown cows (four affected and four controls) for SNP development in the three positional candidate genes and the 17 genes evenly distributed over the QTL region.

###### PCR-Primers for SNP-genotyping.

  **Gene**   **Target**   **SNP**                                                                                         **Primer**            **Primer sequence (5′→3′)**   **Annealing temperature (°C)**   **Product size (bp)**
  ---------- ------------ ----------------------------------------------------------------------------------------------- --------------------- ----------------------------- -------------------------------- -----------------------
  *TNNT1*    intron 10    [AM930546](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930546) ; g.273A\>G   TNNT1_SNPex11_F       CAGAGTTGGGGATGGATATG          58                               597
                                                                                                                          TNNT1_SNPex11_R2      AGACCAGAGGGATGTGTTGG                                           
             exon 11      [AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555) ; c.359A\>G   TNNT1_SNPex11_F       CAGAGTTGGGGATGGATATG          58                               597
                                                                                                                          TNNT1_SNPex11_R2      AGACCAGAGGGATGTGTTGG                                           
             exon 13      [AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555) ; c.425A\>C   TNNT_SNP_ex13_F2      CTGACACCCCTCCTTCTCCT          58                               157
                                                                                                                          TNNTex8--13_R         CCCAGATGGACACACACC                                             
  *RDH13*    5′UTR        [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.57A\>C    RDH13_ex1_F\_gen      GCGCTCTAGGTGCAGACTC           60                               381
                                                                                                                          RDH13_ex1_R\_gen      CCGGAAGCAACTAGACCAAA                                           
             exon 1       [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.103C\>G   RDH13_ex1_F\_gen      GCGCTCTAGGTGCAGACTC           60                               381
                                                                                                                          RDH13_ex1_R\_gen      CCGGAAGCAACTAGACCAAA                                           
             intron1      [AM930548](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930548) ; g.294C\>T   RDH13_ex1_F\_gen      GCGCTCTAGGTGCAGACTC           60                               381
                                                                                                                          RDH13_ex1_R\_gen      CCGGAAGCAACTAGACCAAA                                           
             exon 2       [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.151C\>T   RDH13_ex2_F\_gen      CCTTGGGTTGTGGGATATTG          60                               338
                                                                                                                          RDH13_ex2_R\_gen      CCAACCACCACCAGGTCTTA                                           
             intron 2     [AM930549](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930549) ; g.8G\>A     RDH13_ex3_F\_gen      TTTTCTCGTCTGGCTCTTCC          60                               307
                                                                                                                          RDH13_ex3_R\_gen      TCTTCACCCAAAGACGGAAC                                           
             intron 3     [AM930550](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930550) ; g.137T\>C   RDH13_ex4_F\_gen      CCAGGTAGTTAACGCCAAGC          58                               372
                                                                                                                          RDH13_ex4_R\_gen      TGCCTTTCTCTGGCTCACTT                                           
             exon 5       [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.703C\>A   RDH13_SNPex5_F        GCCACTTCCTTTTGACGAAC          60                               355
                                                                                                                          RDH13_SNPex5_R        GTCGGGCCTAAGTGTGTCAT                                           
             exon 7       [AM930554](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930554) ; c.491G\>C   RDH13_SNPex7_F        GGTTCCTGCATCTGGAATTG          60                               381
                                                                                                                          RDH13_SNPex7_R        ACTTTCAGCCCAAAGCCTCT                                           
  *TFPT*     exon 2       [AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551) ; c.337A\>T   TFPT_SNPex3_F         GGCTTGAGCTGTCCAGTGA           60                               387
                                                                                                                          TFPT_SNPex3_R         TGCGATTTAGTTCCCTCTGG                                           
             exon 2       [AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551) ; c.379G\>T   TFPT_SNPex3_F         GGCTTGAGCTGTCCAGTGA           60                               387
                                                                                                                          TFPT_SNPex3_R         TGCGATTTAGTTCCCTCTGG                                           
             exon 5       [AM930552](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930552) ; c.176G\>A   TFPT_exon6_SNP_genF   CTCTCCCGTCTGCCAGGAT           62                               297
                                                                                                                          TFPT_exon6_SNP_genR   CTTTCCCTGCTTCCCCTGT                                            

The PCR-primers for amplification of the genomic sequences of bovine *TNNT1*, *RDH13*, and *TFPT* genes which contain the SNP markers are shown.

###### PCR-primers used for SNP development on genomic DNA.

  **Gene**     **Position HSA19 (Mb)**   [BLAST](http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9913)  **hit BTA18 (Mb)**   **Primer name**   **Primer sequence (5′ -\> 3′)**   **Primer location**   **Product size (bp)**
  ------------ ------------------------- ------------------------------------------------------------------------------------------------------ ----------------- --------------------------------- --------------------- -----------------------
  *KCNJ14*     53.65                     54.98                                                                                                  KCNJ14_F          CCAGGGTTGGTGTGAGAACT              exon 2                342
                                                                                                                                                KCNJ14_R          GCTCTTCCTACCTCCCTGGT              exon 2                
  *CA11*       53.83                     55.1                                                                                                   CA11_F            GAAACTTCGTGCCAGGTG                exon 2                938
                                                                                                                                                CA11_R            CACCAGGGTTCTTACCTTCTC             intron 3              
  *DHDH*       54.13                     55.34                                                                                                  DHDH_F            AGCTTCACCTGCAGCATC                exon 5                955
                                                                                                                                                DHDH_R            TCCTTATGCTCCCCCTTC                exon 6                
  *BAX*        54.15                     55.35                                                                                                  BAX_F             TCAGGGGTGAGTTTGAGGTC              exon 2                556
                                                                                                                                                BAX_R             GGTCCACCCAAACCAAAGA               intron 3              
  *HRC*        54.35                     55.47                                                                                                  HRC_F1            TGGTCTGCGAAACTCTCTG               exon 7                530
                                                                                                                                                HRC_R1            CAGGGACGAGGAGAAATAGTC             exon 8                
                                                                                                                                                HRC_F2            TAACCTGGCTCCTCTGGTC               intron 5              652
                                                                                                                                                HRC_R2            GAGCAGAGAGTTTCGCAGAC              exon 7                
  *CPT1C*      54.89                     56.05                                                                                                  CPT1C_F1          TGGACTTTTTCTGACCGACT              intron 3              960
                                                                                                                                                CPT1C_R1          GACTCAATGGGCTCACATCT              intron 6              
                                                                                                                                                CPT1C_F2          GCCATGGAGGACAAAGAGA               exon 15               652
                                                                                                                                                CPT1C_R2          CAGGGCGAGGCACTGTG                 exon 16               
  *KCNC3*      55.52                     56.45                                                                                                  KCNC3_F           CTCCCCATCCACCTTCTC                intron 2              337
                                                                                                                                                KCNC3_R           GCTTCTTGCATCCTGTTCTC              intron 2              
  *MYBPC2*     55.64                     56.55                                                                                                  MYBPC2_F          AAAGATGCTGCTGCCAAG                exon 3                619
                                                                                                                                                MYBPC2_R          TTCTGCTCAGGAGATAAGATCC            intron 3              
  *KLK6*       56.16                     56.92                                                                                                  KLK6_F            ACGTTCTCTCCTCCACCAG               intron 2              549
                                                                                                                                                KLK6_R            GTGCTTGCCCAGGTACAC                exon 4                
  *ETFB*       56.55                     57.33                                                                                                  ETFB_F1           AACCCCTTCTGTGAGATCG               exon 2                347
                                                                                                                                                ETFB_R1           CCAGGTGATTCGCTTCTG                exon 3                
                                                                                                                                                ETFB_F2           CTGGCAGAGAAGGAGAAGG               exon 3                818
                                                                                                                                                ETFB_R2           CTGTCATCTGCCCTGTTTG               exon 4                
  *PRKCG*      59.09                     61.97                                                                                                  PRKCG_F           TCTCCGATCCCTATGTGAAG              exon 6                808
                                                                                                                                                PRKCG_R           AAGTCGTTTCGGGAGGTC                exon 7                
  *TFPT*       59.3                      63.54                                                                                                  TFPT_F            AGTGGAACAGGAGAGGCAGT              intron 2              448
                                                                                                                                                TFPT_R            AGTGCTCAGACAAGGGTGTG              intron 3              
  *TTYH1*      59.62                     62.93                                                                                                  TTYH1_F           AGGAGGAGACTGGCCTTG                exon 7                503
                                                                                                                                                TTYH1_R           CCTGGTTGCAGAGGAAGTAG              exon 8                
  *KIR3DL1*    60.02                     62.79                                                                                                  KIR3DL1_F         TGTGTTCTCGAGCCTCTTG               exon 3                1181
                                                                                                                                                KIR3DL1_R         ATCTGTAGGTGCCCACACTC              exon 4                
  *NALP7*      60.14                     62.87                                                                                                  NALP7_F           ACTCTGAGACACCCGAAGTG              exon 4                863
                                                                                                                                                NALP7_R           AGCTGACATTCAGGGTAACG              exon 5                
  *RDH13*      60.26                     62.77                                                                                                  RDH13_F           AGCCCTCCAGGTGATGTTTA              intron 5              714
                                                                                                                                                RDH13_R           GGTGTCTGTGAGGGTGTGTG              intron 6              
  *TNNT1*      60.34                     62.7                                                                                                   TNNT_F1           CGCCGAAGAGCAAGAATA                exon 1                602
                                                                                                                                                TNNT_R1           AGAGGAGAGAGGGGAGAGG               intron 3              
                                                                                                                                                TNNT_F2           AAAAGGGCCCCAAATTATTA              intron 10             511
                                                                                                                                                TNNT_R2           TCCAGAGAAAGAGGGATGAA              intron 12             
  *SYT5*       60.38                     62.67                                                                                                  SYT5_F            TCACTGGACTATGATTTCCAGAC           exon 4                681
                                                                                                                                                SYT5_R            AGCGGTCGAAGTCGTACA                exon 6                
  *BRSK1*      60.5                      62.56                                                                                                  BRSK1_F           CTCAACTCCATCCGCAAC                exon 15               556
                                                                                                                                                BRSK1_R           GACATCTCCTCGGCAGTG                exon 16               
  *SUV420H2*   60.55                     62.52                                                                                                  SUV420H2_F1       AAAGTGGCTTCACCATCTTG              exon 4                931
                                                                                                                                                SUV420H2_R1       TCTCAGCAGCTCCTCGTC                exon 5                
                                                                                                                                                SUV420H2_F2       GGATGGCCCACTACTTCC                exon 3                493
                                                                                                                                                SUV420H2_R2       CATGGAATAACGGGTACAGG              exon 4                

The gene, its position on HSA19, [BLAST](http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9913) hits on BTA18 (Btau_4.0), F and R primers, primer location, and product size are presented. The annealing temperature for all PCR reactions was 58 °C.

### Polymerase chain reaction and DNA sequencing

We used 48 BCSE-affected German Brown cows and 48 unaffected cows of the same breed. PCR reactions were performed in a total volume of 30 µl using 2 µl (\~20 ng/µl) genomic DNA, 3 µl 10X PCR buffer, 6 µl 10X PCR Enhancer (PeqLab, Erlangen, Germany), 0.6 µl (10 µM) of each primer, 0.6 µl dNTPs (10 mM each), and 0.2 µl (5 U/µl) Taq polymerase (Roche, Mannheim, Germany). The reactions were performed in TProfessional thermocyclers (Biometra, Goettingen, Germany) and started with 5 min initial denaturation at 95 °C followed by 36 cycles at 95 °C for 30 s, optimum annealing temperature (Ta) around 58--60 °C for 1 min, and extension at 72 °C for 45 s. The PCR was completed with a final cooling at 4 °C for 10 min. After purification of the PCR products with MinElute 96 UF Plate (Qiagen), the amplicons were directly sequenced with the DYEnamic ET Terminator Cycle Sequencing kit (GE Healthcare, Freiburg, Germany) on a MegaBACE 1000 capillary sequencer (GE Healthcare). Sequence data was analyzed using the Sequencher 4.7 program (GeneCodes, Ann Arbor, MI).

We analyzed a total of 41 PCR products within 20 genes ([Table 2](#t2){ref-type="table"}, [Table 3](#t3){ref-type="table"}, and [Table 4](#t4){ref-type="table"}). We genotyped all 20 SNPs detected in the cDNA and genomic sequences of the three candidate genes as well as the nine SNPs detected within the additional genes in the BCSE region to obtain a complete sampling from 48 BCSE-affected German Brown cows and 48 unaffected cows of the same breed ([Table 5](#t5){ref-type="table"}).

###### SNP analysis.

  **Gene**     **SNP**                                                                                         **Location**   **Number of**   **Minor allele frequencies (%)**   **HET (%)**   **PIC (%)**   **p (HWE)**          
  ------------ ----------------------------------------------------------------------------------------------- -------------- --------------- ---------------------------------- ------------- ------------- ------------- ------ ----------
  *KCNJ14*     [AM922316](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM922316) ; g.141C\>G   exon 2         32              34                                 50            39.71         34.9          37.2   0.0165
  *DHDH*       [AM930537](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930537) ; g.351A\>C   intron 5       38              34                                 16.88         30.88         36.1          29.6   0.9928
  *BAX*        [AM930538](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930538) ; g.493T\>C   intron 3       43              40                                 18.6          11.25         25.3          22.3   0.9197
  *CPT1C*      [AM930539](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930539) ; g.569A\>G   intron 15      43              43                                 22.09         36.05         39.5          32.7   0.7016
  *PRKCG*      [AM930540](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930540) ; g.161C\>T   intron 6       43              40                                 32.56         32.5          36.1          34.3   0.1077
  *SUV420H2*   [AM930545](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930545) ; g.129C\>T   intron 4       34              41                                 20.59         20.73         33.3          27.4   0.8861
  *SYT5*       [AM930544](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930544) ; g.71G\>A    intron 4       39              36                                 7.69          16.67         24            18.9   0.2376
  *TNNT1*      [AM930546](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930546) ; g.273A\>G   intron 10      43              39                                 6.98          5.13          9.8           10.8   0.18
  *TNNT1*      [AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555) ; c.359A\>G   exon 11        33              31                                 22.73         4.84          21.6          21.3   \<0.0001
  *TNNT1*      [AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555) ; c.425A\>C   exon 13        40              40                                 23.75         26.25         32.5          30.5   0.233
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.57A\>C    5′UTR          48              47                                 39.58         35.11         49.5          35.9   0.579
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.103C\>G   exon 1         48              46                                 22.92         29.35         35.1          31.1   0.3876
  *RDH13*      [AM930548](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930548) ; g.294C\>T   intron1        32              30                                 13.75         11.29         41.7          35.9   0.8591
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.151C\>T   exon 2         46              46                                 19.57         13.04         30.4          23.6   0.2694
  *RDH13*      [AM930549](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930549) ; g.8G\>A     intron 2       46              45                                 11.96         12.22         22            19     0.745
  *RDH13*      [AM930550](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930550) ; g.137T\>C   intron 3       45              40                                 12.22         21.25         25.9          23.7   0.5842
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.703C\>A   exon 5         48              45                                 11.46         21.11         23.7          23.4   0.2257
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.113G\>C   intron 5       40              38                                 17.5          23.68         30.8          27.3   0.6181
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.194C\>T   intron 5       44              43                                 11.36         20.93         27.6          23.4   0.8409
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.333C\>T   intron 6       41              43                                 17.07         19.77         8.7           8      0.9192
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.378A\>G   intron 6       39              42                                 14.29         20.24         19.8          25.6   0.6617
  *RDH13*      [AM930554](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930554) ; c.491G\>C   exon 7         48              43                                 7.29          21.28         44            29.9   0.9942
  *NALP7*      [AM930543](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930543) ; g.103T\>G   intron 4       29              35                                 45.35         26.32         23.4          18.6   0.2883
  *TTYH1*      [AM930542](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930542) ; g.365G\>A   intron7        29              35                                 17.24         7.14          23.4          18.6   0.2883
  *TFPT*       [AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551) ; c.337A\>T   exon 2         7               7                                  7.14          0             7.1           6.7    0.8898
  *TFPT*       [AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551) ; c.379G\>T   exon 2         7               7                                  7.14          0             7.1           6.7    0.8898
  *TFPT*       [AM930541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930541) ; g.120T\>C   intron 2       48              47                                 8.33          14.89         23.2          18.4   0.2018
  *TFPT*       [AM930541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930541) ; g.342G\>A   intron 3       39              42                                 2.56          3.57          6.2           5.8    0.7744
  *TFPT*       [AM930552](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930552) ; c.176G\>A   exon 5         7               7                                  7.14          0             7.1           6.7    0.8898

The intragenic single nucleotide polymorphisms (SNPs, n=29) are shown with their number of genotyped cases and controls, minor allele frequencies of genotyped cases and controls, polymorphism information content (PIC), heterozygosity (HET), and test results for Hardy--Weinberg equilibrium (HWE).

Statistical analyses
--------------------

A case-control analysis based on χ^2^-tests for genotypes, alleles, and trend of the alleles was performed using the CASECONTROL procedure of SAS/Genetics (SAS, version 9.1.3; Statistical Analysis System, Cary, NC). The ALLELE procedure of SAS was used for estimation of allele frequencies and tests for Hardy--Weinberg equilibrium (HWE) of genotype frequencies. Statistical calculation of pairwise linkage disequilibrium (LD) was performed and pictured using [HAPLOVIEW 4.0](http://www.broad.mit.edu/mpg/haploview/) \[[@r31]\]. We used the Tagger algorithm r^2^≥0.8 \[[@r32]\] to detect SNPs with strong LD among alleles. Subsequently, the association of haplotypes with BCSE was tested using the HAPLOTYPE procedure of SAS/Genetics.

Results
=======

Hardy--Weinberg equilibrium and minor allele frequencies
--------------------------------------------------------

In total, we developed 29 SNPs within 12 genes. Of these 29 SNPs, 20 were located within the three candidate genes, *TNNT1*, *RDH13*, and *TFPT*. The other nine SNPs were discovered in nine different genes located in the 8.56 Mb interval between LOC540740 (similar to inward rectifier potassium channel*)* and *TFPT*. The genotypic distributions of the 27 genotyped SNPs were in Hardy--Weinberg equilibrium. The SNPs within LOC540740 and exon 11 of *TNNT1* were not in Hardy--Weinberg equilibrium. Thus, these SNPs were not considered in the subsequent association analyses. The results of the tests for HWE, the observed heterozygosity (HET), polymorphism information content (PIC), and minor allele frequencies for the developed SNPs are shown in [Table 5](#t5){ref-type="table"}.

Mutation analysis within bovine *TNNT1*, *RDH13*, and *TFPT*
------------------------------------------------------------

We revealed a total of 10 exonic SNPs within the three candidate genes and a new splice variant of *TNNT1* ([Table 5](#t5){ref-type="table"}). Furthermore, we detected 10 SNPs in the intronic sequences of these candidate genes ([Figure 3](#f3){ref-type="fig"} and [Figure 4](#f4){ref-type="fig"}).

![Gene structure and detected single nucleotide polymorphisms within the candidate genes. The gene structure and the detected SNPs within *TNNT1* (9,366 bp), *RDH13* (16,985 bp), and *TFPT* (7,644 bp) are shown. The positions of the SNPs are indicated by arrows. Translated exons are shown as solid boxes and numbered with Arabic numerals. Untranslated regions of exons are shown as open boxes.](mv-v14-1737-f3){#f3}

![Splice variant of *TNNT1.* **A**: The genomic structure of *TNNT1* is shown. **B**: Detailed illustration of the genomic region from exon 3 to exon 5 is given. **C**: The mRNA sequence of exon 4, their flanking sequences, and the corresponding translated amino acids are pictured. Translated exons are shown as solid boxes. Untranslated regions are shown as gray bars. The exons are numbered by Arabic numerals. The length in base pairs is given for each sequence. Exon 4 is marked in red. The corresponding mRNA sequence and the translation product of exon 4 are printed in *italics*.](mv-v14-1737-f4){#f4}

TNNT1
-----

Two exonic SNPs are located in the coding sequence of *TNNT1*. One SNP was found in exon 11 and the second in exon 13. Both SNPs did not affect the amino acid sequence. We also identified a deletion of 33 base pairs in the cDNA sequence from eye muscle tissue of all six cows. These 33 base pairs conform to exon 4 of the published bovine mRNA ([NM_174474](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=41386696); [Figure 4](#f4){ref-type="fig"}). In contrast, the cDNA isolated from the retina showed that all tested animals were heterozygous for this splice variant. In nerve tissue, all three genotypes were found. In addition, we found one SNP within intron 10.

RDH13
-----

In *RDH13*, five exonic SNPs were detected. An A\>C transversion ([AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555); c.425A\>C) is located in the 5′UTR 14 bases upstream of the start codon. A C\>G SNP ([AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553); c.103C\>G) is located at position 151 of bovine mRNA ([NM_001075345](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=115496473)) in exon 1. This SNP changes a CGG triplet to a GGG triplet and thus causes an amino acid exchange from arginine to glycine (p.Arg11Gly). This means there is a change from a charged alkaline amino acid to a nonpolar amino acid. The second SNP ([AM930554](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930554); c.491G\>C), which results in an amino acid exchange from glutamine to glutamate (p.Gln233Glu), was found at position 33 of bovine exon 7. This G\>C transversion changes a GAG triplet to a CAG triplet, which has the effect that a polar and uncharged amino acid is replaced by an acidic, nonpolar, and charged amino acid in the primary structure of the protein. In addition, we detected two synonymous SNPs in the coding sequence of exon 2 and 5. Within the introns of *RDH13*, we detected one SNP in introns 1, 2, and 3 and two SNPs each in intron 5 and 6 ([Table 5](#t5){ref-type="table"}).

TFPT
----

In the coding sequence of *TFPT*, we identified three exonic SNPs. Two of them are located at positions 2 and 44 of exon 2. Both mutations affect the protein structure. The first exon 2 SNP ([AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551); c.337A\>T) is an A\>T transversion, which causes an amino acid exchange from threonine to serine (p.Thr9Ser). However, both amino acids are polar, uncharged, and differ in only one ─CH~3~ side chain. The second SNP ([AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551); c.379G\>T) in exon 2 alters the protein structure due to a G\>T transversion, which changes a GGC triplet to a TGC triplet (p.Gly23Cys). This means that the nonpolar amino acid, glycine, is exchanged with the polar, sulfur-containing amino acid, cysteine. The third exonic SNP found in the ORF of *TFPT* is a synonymous mutation. This G\>A SNP ([AM930552](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930552); c.176G\>A) at position 72 in exon 5 changes a CTG to a CTA triplet, which has no effect on the amino acid sequence of *TFPT*. In addition, we identified one SNP in introns 2 and 3 of *TFPT*.

Association analysis
--------------------

We detected four SNPs significantly associated with BCSE. These were located in *DHDH*, *CPT1C*, *TNNT1*, and *NALP7* ([Table 5](#t5){ref-type="table"} and [Table 6](#t6){ref-type="table"}). An exonic A\>G transition ([AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555); c.359A\>G) within *TNNT1* reached significant results in allele and trend test statistics ([Table 6](#t6){ref-type="table"}).

###### Single marker association.

  **Gene**     **SNP**                                                                                         **χ^2^ allele**   **p allele**   **χ^2^ genotype**   **p genotype**   **χ^2^ trend**   **p trend**
  ------------ ----------------------------------------------------------------------------------------------- ----------------- -------------- ------------------- ---------------- ---------------- -------------
  *KCNJ14*     [AM922316](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM922316) ; g.141C\>G   1.41              0.235          1.58                0.454            1.09             0.296
  *DHDH*       [AM930537](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930537) ; g.351A\>C   3.78              0.052          3.79                0.151            3.78             0.052
  *BAX*        [AM930538](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930538) ; g.493T\>C   1.75              0.186          2.39                0.303            1.73             0.188
  *CPT1C*      [AM930539](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930539) ; g.569A\>G   4.06              0.044          7.51                0.023            3.9              0.048
  *PRKCG*      [AM930540](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930540) ; g.161C\>T   \<0.001           0.994          0.58                0.749            \<0.001          0.994
  *SUV420H2*   [AM930545](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930545) ; g.129C\>T   \<0.001           0.983          3.78                0.151            \<0.001          0.983
  *SYT5*       [AM930544](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930544) ; g.71G\>A    2.86              0.091          3.31                0.069            3.31             0.069
  *TNNT1*      [AM930546](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930546) ; g.273A\>G   0.24              0.621          2.82                0.244            0.21             0.645
  *TNNT1*      [AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555) ; c.359A\>G   8.47              0.004          4.74                0.094            4.53             0.033
  *TNNT1*      [AM930555](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930555) ; c.425A\>C   0.13              0.715          0.95                0.622            0.11             0.732
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.57A\>C    0.41              0.524          1.51                0.469            0.43             0.511
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.103C\>G   1                 0.315          2.4                 0.301            0.93             0.336
  *RDH13*      [AM930548](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930548) ; g.294C\>T   0.19              0.662          2.44                0.295            0.19             0.659
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.151C\>T   1.43              0.231          1.97                0.374            0.9              0.203
  *RDH13*      [AM930549](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930549) ; g.8G\>A     0.003             0.956          1.18                0.552            0.003            0.955
  *RDH13*      [AM930550](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930550) ; g.137T\>C   2.51              0.113          2.44                0.295            2.37             0.124
  *RDH13*      [AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553) ; c.703C\>A   3.2               0.074          2.84                0.241            2.84             0.092
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.113G\>C   0.91              0.339          1.34                0.513            0.87             0.352
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.194C\>T   2.94              0.086          3.45                0.177            3.01             0.083
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.333C\>T   0.2               0.653          0.33                0.85             0.2              0.655
  *RDH13*      [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547) ; g.378A\>G   0.002             0.965          1.56                0.459            0.002            0.966
  *RDH13*      [AM930554](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930554) ; c.491G\>C   1.61              0.205          1.61                0.445            1.61             0.205
  *NALP7*      [AM930543](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930543) ; g.103T\>G   6.31              0.012          5.57                0.062            5.38             0.02
  *TTYH1*      [AM930542](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930542) ; g.365G\>A   3.13              0.077          3.61                0.058            3.61             0.058
  *TFPT*       [AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551) ; c.337A\>T   1.04              0.309          1.08                0.299            1.08             0.299
  *TFPT*       [AM930551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930551) ; c.379G\>T   1.04              0.309          1.08                0.299            1.08             0.299
  *TFPT*       [AM930541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930541) ; g.120T\>C   2                 0.158          2.3                 0.13             2.3              0.13
  *TFPT*       [AM930541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930541) ; g.342G\>A   0.14              0.711          0.14                0.707            0.14             0.707
  *TFPT*       [AM930552](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930552) ; c.176G\>A   1.04              0.309          1.08                0.299            1.08             0.299

The results of association analysis of 29 intragenic SNPs with bilateral convergent strabismus with exophthalmos in German Brown cattle, their χ^2^-test statistics of the case-control analysis, and their error probabilities (p) are presented.

The SNPs within the exons and the exon flanking intronic sequences of *RDH13* showed no significant results from the χ^2^ tests for distribution of genotypes between cases and controls. The χ^2^ test statistics for allelic distributions between cases and controls ranged from 0.003 to 3.20 and their error probabilities from 0.07 to 0.97 for the *RDH13* SNPs. Four exon SNPs clearly failed the threshold of significance. Only the C\>A SNP ([AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553); c.703C\>A) in exon 5 with an allelic χ^2^ value of 3.20 was close to the threshold of 0.05 ([Table 6](#t6){ref-type="table"}).

The exonic SNPs of *TFPT* were not genotyped for the complete sample due to their low minor allele frequency ([Table 5](#t5){ref-type="table"}), and the other intronic SNPs were not associated with BCSE ([Table 6](#t6){ref-type="table"}).

Linkage disequilibrium and haplotype association
------------------------------------------------

The r^2^ values indicated strong linkage disequilibrium (LD) for the SNPs between intron 1 and intron 2 of *RDH13*. By tagging with threshold r^2^≥0.8, we detected five SNPs in *RDH13*, which were representative for the total of 12 *RDH13* SNPs. Therefore, only these five SNPs of *RDH13* were used in the haplotype association analysis. The SNPs within the other genes were not in LD ([Figure 5](#f5){ref-type="fig"}).

![Linkage disequilibria and positions of the single nucleotide polymorphisms on the telomeric end of BTA18. LD coefficients (r^2^) between the SNP pairs are indicated, and the position on BTA18 is pictured. Red fields with black font display r^2^ values greater than 0.50. White and lilac fields display r^2^ values less than 0.15.](mv-v14-1737-f5){#f5}

We tested the association of haplotypes with BCSE including three to eight SNPs and permutated the number of SNPs that were in Hardy--Weinberg equilibrium. The marker-trait association including five SNPs located in the genes, *CPT1C* ([AM930539](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930539); g.569A\>G), *SYT5* ([AM930544](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930544); g.71G\>A), *RDH13* ([AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553); c.703C\>A and [AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547); g.194C\>T), and *NALP7* ([AM930543](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930543); g.103T\>G), was significant (χ^2^=54.11, p\<0.0001). In total, there were eight different haplotypes of these markers that had a frequency of at least 1% ([Table 7](#t7){ref-type="table"}). Three individual haplotypes were significantly associated with the affected status and occurred with a frequency of more than 5% in our sample. The A-G-C-C-G haplotype occurred with a frequency of 31.7% in our sample of affected cows and with a frequency of 9.4% in the controls. The A-G-A-T-T haplotype occurred with a frequency of 17.1% in the sample of unaffected cows and with a frequency of 6.1% in the affected cows. The third associated haplotype (G-G-C-C-T) was found with a frequency of 17.0% in our sample of unaffected cows and with a frequency of 7.0% in the affected cows ([Table 7](#t7){ref-type="table"}). The significantly associated haplotypes spanned the region from *CPT1C* (56.05 Mb) to *NALP7* (62.87 Mb) on the telomeric end of BTA18. Further, two haplotypes adjacent to the proximal and distal region of this aforementioned associated region were tested for association with BCSE. The first haplotype proximally to *CPT1C* consisted of the SNPs ([AM922316](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM922316); g.141C\>G, [AM930537](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930537); g.351A\>C, [AM930538](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930538); g.493T\>C), and the second haplotype distally to *NALP7* included the SNPs ([AM930542](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930542); g.365G\>A, [AM930541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930541); g.120T\>C, [AM930541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930541); g.342G\>A). Both adjacent haplotypes did not show significant results in marker-trait association tests with BCSE (χ^2^=11.7, p =0.07 corresponds to the first haplotype proximally to the BCSE-associated region and χ^2^=7.3, p=0.12 corresponds to the second haplotype distally to the BCSE-associated region).

###### Haplotype association.

  **SNP**   **Haplotype**   **Frequency total (%)**   **Standard error**   **Frequency (%)**   **χ^2^**    **p**                                    
  --------- --------------- ------------------------- -------------------- ------------------- ----------- ------- -------- ------- ------- ------- --------
  A         G               C                         C                    T                   A-G-C-C-T   28.02   0.0325   21.63   33.94   3.6     0.0575
  A         G               C                         C                    G                   A-G-C-C-G   23.2    0.0305   9.39    31.68   14.01   0.0002
  G         G               C                         C                    G                   G-G-C-C-G   10.87   0.0187   14.26   11.16   1.12    0.2889
  A         G               A                         T                    T                   A-G-A-T-T   10.03   0.0176   17.08   6.17    6.79    0.0092
  G         G               C                         C                    T                   G-G-C-C-T   9.79    0.0139   16.95   6.96    6.35    0.0117
  A         A               C                         C                    T                   A-A-C-C-T   7.73    0.0112   9.93    5.36    1.41    0.2351
  G         G               A                         T                    T                   G-G-A-T-T   3.23    0.0109   2.05    2.34    0.67    0.4132
  G         A               C                         C                    T                   G-A-C-C-T   3.09    0.0106   2.55    2.38    0.26    0.6126

Frequencies of the haplotypes with a frequency of at least 1% in the total sample of 96 German Brown cattle and their standard errors, haplotype frequencies of cases and controls, and their association with BCSE on bovine chromosome 18 are shown. In the \"SNP\" column, SNP 1=[AM930539](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930539); g.569A\>G within *CPT1C*; SNP 2=[AM930544](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930544); g.71G\>A within *SYT5*; SNP 3=[AM930553](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930553); c.703C\>A within exon 5 of *RDH13*; SNP 4=[AM930547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930547); g.194C\>T within intron 5 of *RDH13*; and SNP 5=[AM930543](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=AM930543); g.103T\>G within *NALP7*.

Discussion
==========

We developed a total of 29 intragenic SNPs within an 8.56 Mb region on BTA18 extending from *LOC540740* to *TFPT*. In a previously performed whole genome scan, this region was found to be linked with BCSE in German Brown dairy cattle \[[@r7]\]. Within the genes, *CPT1C* and *NALP7*, two SNPs were significantly associated with BCSE in association tests for single markers. Within *DHDH*, *TTYH1*, and *SYT5*, three more SNPs reached values close to the significance threshold of p=0.05.

Most of the 29 SNPs were detected in the sequences of the potential candidate genes, *RDH1*3, *TFPT*, and *TNNT1*. We identified four missense mutations within the coding sequence of these three genes and also detected a new splice variant of *TNNT1*. Since none of the SNPs within the genes (*RDH1*3, *TFPT*, and *TNNT*) were significantly associated with BCSE in association tests for single markers, these genes are unlikely to be causal for this eye defect. However, the detected polymorphisms may be of importance in studies for other bovine diseases especially the SNPs within *RDH13*. These SNPs could be involved in the genetic pathology of retinal dystrophy or related diseases like the defects reported to be associated to other members of the short-chain dehydrogenases/reductases (SDR) family \[[@r27],[@r28]\].

In cattle, genes influencing the development of strabismus are not yet known. Therefore, neuromuscular eye-disorders in humans with already identified causal genes and even developmental and biological characteristics may be used as candidates for BCSE. However, all potential candidate genes characterized as causal for these syndromes (*PEO*, *CFEOM*, and *DRS*) in humans \[[@r11]-[@r25]\] could be ruled out for bovine BCSE because we could not find linkage or these candidate genes did not map in the BCSE-linked region on BTA18.

We employed haplotype analysis to further refine the BCSE region on BTA18. To find the most likely associated haplotype, we permutated the number of SNPs for the different haplotypes within this region and were then able to find a significantly associated haplotype. This haplotype included SNPs from the genes *CPT1C*, *SYT5*, *RDH13*, and *NALP7*. Presence of the haplotype A-G-C-C-G composed of these five SNPs indicated a high probability of an animal to be affected by BCSE later in life whereas the haplotypes A-G-A-T-T and G-G-C-C-T were related with low risk to BCSE. Because the surrounding SNPs did not contribute to the significance of the haplotype association, confirmation has been obtained that this linked BCSE region could be delimited using haplotype analysis. Robustness of the haplotype association was furthermore evident when the surrounding haplotypes were extended with one or three adjacent SNPs from the associated haplotype region. In these cases, the extended haplotypes reached higher χ^2^-test statistics and lower error probabilities as more SNPs of the associated region were included. This result was according to our expectation for this region. In conclusion, the haplotype association refined the BCSE region to a 6.82 Mb interval.

To detect the gene responsible for bovine BCSE, further SNPs have to be developed within this BCSE region spanning from 56.05 Mb to 62.87 Mb on BTA18. Haplotype analysis may then be a valuable tool to determine the most likely BCSE causing gene.

Particularly, SNPs within potential candidate genes like *CPT1C* will be considered. *CPT1C* is located at 54.89 Mb on HSA19 and specifically expressed within the endoplasmic reticulum (ER) in neurons of the brain \[[@r33]\]. Expression was also detected in the retinal pigment epithelium \[[@r34]\]. The function of this gene is not yet clearly defined. *CPT1C* is believed to modulate the palmitoyl-CoA pool associated with the ER and therefore to regulate the synthesis of ceramide and sphingolipids. Ceramide and sphingolipids are important for signal transduction, modification of neuronal membranes, and brain plasticity \[[@r35]-[@r37]\]. Since one of the BCSE-associated SNPs is located within intron 15 of bovine *CPT1C* at 56.05 Mb on BTA18, this gene may be a candidate for BCSE.
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